Nauman Rahim Khan | Pharmaceutical Sciences | Best Researcher Award

Posted on by sciencefather

Assoc. Prof. Dr. Nauman Rahim Khan | Pharmaceutical Sciences | Best Researcher Award

Associate Professor, Kohat University of Science and Technology, Pakistan

Dr. Nauman Rahim Khan is an accomplished academician, researcher, and pharmaceutical scientist. With a B.Pharm, M.Phil, and PhD in Pharmaceutics from UiTM, Malaysia, he has devoted himself to advancing pharmaceutical sciences, specializing in transdermal drug delivery systems, wound healing, and nanotechnology. Dr. Khan holds the position of Associate Professor at the Department of Pharmacy, Kohat University of Science and Technology. His professional career spans over a decade, during which he has made significant contributions to academia and research. He has supervised numerous postgraduate students and has collaborated internationally with institutions such as Najran University, KSA, and UiTM, Malaysia. Dr. Khan is known for his passion for innovation in drug delivery systems and his commitment to improving pharmaceutical practices. His expertise and dedication have earned him numerous awards, including the prestigious Gold Medal at the Malaysia Technology Expo 2017.

Profile

Education

Dr. Nauman Rahim Khan earned his PhD in Pharmaceutics from UiTM, Malaysia (2013-2016), where his research focused on skin delivery using novel techniques like microwave-assisted drug permeation enhancement. Prior to his PhD, he completed an M.Phil in Pharmaceutics from Gomal University D.I. Khan in 2011 with a CGPA of 3.46, and a B.Pharm degree in 2006, securing first position in his class. His academic journey is highlighted by excellence in research and contributions to the field of pharmaceutical sciences. Dr. Khan also undertook further language training, completing a 6-week French language course at NUML Peshawar in 2012. Throughout his career, Dr. Khan has demonstrated a profound commitment to advancing his knowledge and applying it in practical pharmaceutical applications.

Experience

Dr. Nauman Rahim Khan has a distinguished teaching career spanning over 15 years. He currently serves as an Associate Professor at the Department of Pharmacy, Kohat University of Science and Technology. Prior to this role, he was a Lecturer in Pharmaceutics at Gomal University D.I. Khan from 2008 to 2021. In addition to his academic responsibilities, Dr. Khan has held several key administrative positions, including Deputy Director of the Quality Enhancement Cell and Program Director for the HEC “Ehsas Undergraduate Scholarship Project.” He has also been a member of various university committees, including the Pharmacy Council of Pakistan. Dr. Khan has supervised numerous M.Phil and PhD students and continues to be an active mentor in the academic community. His experience extends beyond teaching, as he has been involved in national and international research collaborations, further enhancing his role as a researcher and educator.

Awards and Honors

Dr. Nauman Rahim Khan has received multiple prestigious awards throughout his career. Notably, he was honored with the Gold Medal at the Malaysia Technology Expo 2017 for his innovative work on microwave-assisted skin drug delivery. He also received the TEFARCO Innova-PharmaTech Scientists Award in 2016 at PharmaBioAsia. In recognition of his academic excellence, Dr. Khan was awarded the University Gold Medal from Gomal University for securing the first position in his B.Pharm program (2002-2006). His remarkable achievements include winning the “Presidential Scholarship Award” from the Ministry of Health, Islamabad, Pakistan, and being selected for the “Interprovincial Exchange of Students Delegations” program. Additionally, Dr. Khan’s overseas PhD scholarship by the Higher Education Commission of Pakistan further reflects his outstanding academic prowess. His continued success has earned him recognition in both national and international forums.

Research Focus

Dr. Nauman Rahim Khan’s research primarily focuses on advanced drug delivery systems, with particular interest in skin drug delivery technologies and wound healing. His work includes developing polymeric nanoparticles, nano-ethosomes, and transdermal drug delivery systems for enhanced therapeutic efficacy. Dr. Khan’s research on microwave-assisted drug delivery systems aims to improve the skin permeation of various pharmaceuticals, particularly in the treatment of burns and diabetic wounds. He also explores the use of nanocomposites for wound healing, including burn and diabetic wounds, and is actively involved in the development of novel drug carriers. Additionally, his research delves into the application of 3D printing in pharmaceutical sciences, allowing for customized drug formulations. Dr. Khan is committed to translating his research into practical solutions for improved healthcare, particularly in developing novel formulations for drug delivery and tissue regeneration.

Publication Top Notes

  1. “Nanocarriers and their Actions to Improve Skin Permeability and Transdermal Drug Delivery” 📦💊
  2. “Microwave-aided skin drug penetration and retention of 5-fluorouracil-loaded ethosomes” 🌡️💉
  3. “Formulation and in vitro evaluation of clotrimazole gel containing almond oil and tween 80 as penetration enhancer for topical application” 🧴🌰
  4. “5-Fluorouracil ethosomes–skin deposition and melanoma permeation synergism with microwave” 🔬🧴
  5. “Physico-chemical based mechanistic insight into surfactant modulated sodium Carboxymethylcellulose film for skin tissue regeneration applications” 💡🧪
  6. “3D printing technology: A new approach for the fabrication of personalized and customized pharmaceuticals” 🖨️💊
  7. “Effect of olive oil on transdermal penetration of flurbiprofen from topical gel as enhancer.” 🍈💧
  8. “Formulation and evaluation of microwave-modified chitosan-curcumin nanoparticles—a promising nanomaterials platform for skin tissue regeneration applications following burn wounds” 🌿🔥

 

 

 

Mahnoor Gondal | Bioinformatics | Best Researcher Award

Posted on by sciencefather

Ms. Mahnoor Gondal | Bioinformatics | Best Researcher Award

PhD Candidate at University of Michigan, United States.

Mahnoor Naseer Gondal is a dedicated bioinformatics researcher specializing in single-cell transcriptomics and cancer immunotherapy. Pursuing her Ph.D. at the University of Michigan 🏛️, she works under the mentorship of Dr. Arul Chinnaiyan and Dr. Marcin Cieslik. With a strong academic background from LUMS 🎓 and numerous high-impact publications in journals like Nature, Cancer Discovery, and PNAS 📄, she is shaping the future of precision oncology. Passionate about computational biology, immune-oncology, and translational medicine 🧑‍🔬, she strives to integrate cutting-edge bioinformatics tools to advance personalized cancer treatment.

Professional Profile:

ORCID

Google Scholar

Suitability for Best Researcher Award

Mahnoor Naseer Gondal is a highly qualified candidate for the Best Researcher Award, given her exceptional contributions to the field of bioinformatics, cancer immunotherapy, and single-cell transcriptomics. Her research focuses on precision oncology, leveraging computational biology and AI to improve personalized cancer treatments.

Education & Experience 🎓🔬

✅ Ph.D. (Bioinformatics) – University of Michigan, USA (2021–Present)
📌 MS (Bioinformatics) – University of Michigan, USA (2021–2023)
📌 B.S. (Biology) – Lahore University of Management Sciences (LUMS), Pakistan (2016–2020)

👩‍🔬 Research Experience
🔹 Works on cancer immunotherapy, single-cell RNA sequencing, and tumor microenvironment analysis 🏥
🔹 Published in top-tier journals like Nature, Cancer Discovery, and Scientific Reports 📄
🔹 Contributor to cancer database integration and precision medicine models 🖥️

Professional Development 🌍📚

Mahnoor actively engages in scientific conferences, including AACR (American Association for Cancer Research) 🏅 and Frontiers in Bioinformatics. She has collaborated with leading cancer research labs to develop novel bioinformatics models and enhance therapeutic strategies for immune checkpoint blockade and tumor microenvironment analysis 🧑‍⚕️. She is also mentoring young researchers in computational biology while participating in global workshops on machine learning, data science, and translational medicine. With a passion for bridging biology and AI 🤖, she continues to drive biomedical advancements for precision oncology.

Research Focus 🧬🔍

Mahnoor’s research primarily revolves around cancer systems biology, single-cell transcriptomics, and immune-oncology. Her expertise includes:
🔬 Single-cell RNA sequencing to study tumor heterogeneity and immune resistance 🧑‍⚕️
🧪 Non-coding RNA mechanisms in colorectal cancer for better therapeutic targeting
🖥️ Integration of cancer datasets to enhance personalized treatment approaches
🦠 Immunotherapy resistance mechanisms to develop more effective cancer treatments
⚕️ Computational modeling of cancer for identifying new biomarkers and drug targets

Awards & Honors 🏆🎖️

🏅 Best Research Paper Award – Frontiers in Oncology (2021)
📜 AACR Research Recognition Award – American Association for Cancer Research (2024)
🏆 Outstanding Graduate Researcher Award – University of Michigan (2023)
🔬 Special Issue Publication Recognition – Featured in high-impact oncology journals
🌍 Invited Speaker at AACR, Cancer Research Conferences, and Bioinformatics Summits

Publication Top Notes

  • Title: A Systematic Overview of Single-Cell Transcriptomics Databases, their Use Cases, and Limitations

    • Authors: MN Gondal, SUR Shah, AM Chinnaiyan, M Cieslik
    • Citations: 43
    • Year: 2024

  • Title: Navigating multi-scale cancer systems biology towards model-driven clinical oncology and its applications in personalized therapeutics

    • Authors: MN Gondal, SU Chaudhary
    • Citations: 37
    • Year: 2021

  • Title: A personalized therapeutics approach using an in silico Drosophila patient model reveals optimal chemo-and targeted therapy combinations for colorectal cancer

    • Authors: MN Gondal, RN Butt, OS Shah, MU Sultan, G Mustafa, Z Nasir
    • Citations: 29
    • Year: 2021

  • Title: A cyanobacterial photorespiratory bypass model to enhance photosynthesis by rerouting photorespiratory pathway in C3 plants

    • Authors: G Khurshid, AZ Abbassi, MF Khalid, MN Gondal, TA Naqvi, MM Shah
    • Citations: 27
    • Year: 2020

  • Title: TISON: a next-generation multi-scale modeling theatre for in silico systems biology

    • Authors: MN Gondal, MU Sultan, A Arif, A Rehman, HA Awan, Z Arshad
    • Citations: 23
    • Year: 2021

Wijdan Al-Ahmadi | Biomedicine | Best Researcher Award

Posted on by sciencefatherLeave a Comment on Wijdan Al-Ahmadi | Biomedicine | Best Researcher Award

Dr. Wijdan Al-Ahmadi | Biomedicine | Best Researcher Award

Associate scientest, King Faisal specialist hospital and research center, Saudi Arabia

Dr. Wijdan Al-Ahmadi is a seasoned researcher with over 20 years of experience in biomedicine, focusing on cancer biology, immunology, and disease mechanisms. Based in Riyadh, Saudi Arabia, she is a key member of the Molecular Biomedicine Research Department at King Faisal Specialist Hospital and Research Center. Her work spans diverse fields, including inflammatory diseases and cardiovascular research. Notably, in 2023, she contributed to a groundbreaking experiment aboard the International Space Station (ISS), highlighting her ability to conduct research in extreme environments. Dr. Al-Ahmadi has demonstrated leadership through her work as an educator, mentoring students at various academic levels. Her contributions continue to push the boundaries of biomedicine, paving the way for new therapeutic strategies and personalized medicine approaches.

Profile

Education

Dr. Wijdan Al-Ahmadi holds a Ph.D. in Bioscience from Cardiff University (2015–2019), where she focused on cancer and immunology research. She also earned a B.Sc. in Biochemistry from King Saud University (1994–1998). Her academic journey has equipped her with advanced expertise in molecular biology, cancer research, and biomedical sciences. Dr. Al-Ahmadi’s educational foundation is complemented by her extensive hands-on experience in laboratory settings, which has enabled her to contribute to numerous pioneering studies. Through her formal education and continuous professional development, she has maintained a passion for unraveling disease mechanisms and enhancing health outcomes through scientific innovation.

Experience

Dr. Al-Ahmadi’s career spans over two decades in the field of biomedicine. She currently serves as an Associate Scientist at King Faisal Specialist Hospital and Research Center in Riyadh, where she leads advanced research projects in cancer biology and immunology. Prior to this, she was a Post-doctoral Fellow (2020–2023), focusing on cancer and inflammatory disease mechanisms. Dr. Al-Ahmadi’s experience includes roles as a Research Assistant (2007–2015) and a Research Technician (2002–2006), where she was deeply involved in cancer research and molecular biology assays. She has also mentored Ph.D., master’s, and undergraduate students throughout her career. Her research has had significant impact both in clinical settings and in experimental fields, including innovative studies aboard the ISS in 2023, demonstrating her versatility in different research environments.

Research Focus

Dr. Wijdan Al-Ahmadi’s research is focused on understanding the underlying mechanisms of diseases, particularly cancer, inflammatory disorders, and cardiovascular diseases. She is dedicated to uncovering how specific genetic mutations and signaling pathways contribute to disease progression, aiming to identify novel therapeutic targets for better patient outcomes. Dr. Al-Ahmadi’s work in space science is also notable, having contributed to microgravity research aboard the ISS, exploring how human physiology and disease processes respond in space. Her findings not only have applications for space health but also provide critical insights that can benefit human health on Earth. She is driven by the potential of personalized medicine and therapeutic interventions that address the root causes of disease.

Publication Top Notes

  1. Pro-atherogenic actions of signal transducer and activator of transcription 1 serine 727 phosphorylation in LDL receptor deficient mice via modulation of plaque inflammation. 🧬🔬
  2. Protective effects of a unique combination of nutritionally active ingredients on risk factors and gene expression associated with atherosclerosis in C57BL/6J mice fed a high-fat diet. 🥗🧪
  3. Posttranscriptional control of the chemokine receptor CXCR4 expression in cancer cells. 🧑‍🔬🦠
  4. miR-29a inhibition normalizes HuR over-expression and aberrant AU-rich mRNA stability in invasive cancer. 🧬💡
  5. The RNA-binding zinc-finger protein tristetraprolin regulates AU-rich mRNAs involved in breast cancer-related processes. 🔬💥
  6. Alternative polyadenylation variants of the RNA binding protein, HuR: abundance, role of AU-rich elements and auto-Regulation. 🧬📊
  7. Cloning-free regulated monitoring of reporter and gene expression. 🧬🧑‍🔬
  8. RNase L downmodulation of the RNA-binding protein, HuR, and cellular growth. 🔬🧑‍🔬
  9. Bioinformatics and experimental derivation of an efficient hybrid 3′ untranslated region and use in expression active linear DNA with minimum poly(A) region. 💻🧬
  10. Expedient liquid chromatographic method with fluorescence detection for montelukast sodium in micro-samples of plasma. 🧪💉

 

 

 

Nelly Miteva-Marcheva | Medical Genetics | Best Researcher Award

Posted on by sciencefatherLeave a Comment on Nelly Miteva-Marcheva | Medical Genetics | Best Researcher Award

Assist Prof Dr Nelly Miteva-Marcheva | Medical Genetics | Best Researcher Award

Assist Prof Dr Nelly Miteva-Marcheva, Medical University of Plovdiv, Bulgaria

Dr. Nelly Miteva-Marcheva is a dedicated medical professional specializing in Pediatrics and Medical Genetics. She graduated from the Medical University of Plovdiv in 2015 and became an Assistant Professor at the Department of Medical Genetics in 2019. Since then, she has been committed to integrating advanced training in Medical Genetics into her academic and clinical responsibilities. Dr. Miteva-Marcheva’s research focuses on the intersection of genetics and personalized medicine, aiming to improve patient outcomes through innovative genetic testing and treatments. Her work in implementing DPYD testing for cancer patients and advancing pharmacogenetics in oncology has earned her recognition in the field. With a passion for research and education, Dr. Miteva-Marcheva continues to contribute significantly to the advancement of Medical Genetics.

Publication Profile

Orcid

Strengths for the Award

  1. Academic and Professional Expertise: Dr. Nelly Miteva-Marcheva holds a PhD in Medical Genetics and has specialized training in Pediatrics, showcasing her advanced academic qualifications. Her ongoing role as an Assistant Professor at the Medical University of Plovdiv, coupled with her specialization in Medical Genetics, highlights her commitment to both academia and clinical practice.
  2. Research Contributions: Dr. Miteva-Marcheva has made significant contributions to medical genetics through her published work in high-impact journals, including four publications indexed in SCI and Scopus. Her research on DPYD testing in cancer patients and the application of pharmacogenetics in oncology are noteworthy contributions that have a direct impact on clinical practice and patient care.
  3. Leadership in Research Projects: Dr. Miteva-Marcheva is actively involved in strategic research projects, such as the SRIPD-MUP, indicating her leadership and contribution to advancing medical research in her institution.

Areas for Improvement

  1. Broadened Research Impact: While Dr. Miteva-Marcheva has solid contributions in medical genetics, expanding her research collaborations and contributing to a wider range of interdisciplinary studies could enhance her research impact and visibility.
  2. Editorial and Consultancy Roles: Engaging in editorial appointments and consultancy projects with industry partners would further establish her as a leader in her field, enhancing her candidacy for the Best Researcher Award.

Education 

Dr. Nelly Miteva-Marcheva’s educational journey is marked by a strong foundation in medical sciences and a continuous pursuit of specialized knowledge. She earned her MD from the Medical University of Plovdiv in 2015, laying the groundwork for her medical career. Driven by a passion for pediatrics, she pursued a specialty in this field and obtained her qualification in 2019. Recognizing the importance of genetics in modern medicine, Dr. Miteva-Marcheva further specialized in Medical Genetics starting in 2020. Her dedication to the field led her to complete a PhD in 2024, focusing on groundbreaking research that bridges clinical practice and genetic science. This academic progression not only reflects her commitment to continuous learning but also her desire to make significant contributions to the field of Medical Genetics.

Experience

Dr. Nelly Miteva-Marcheva has amassed a wealth of experience in both clinical practice and academic research. After completing her MD in 2015, she pursued a specialty in Pediatrics, gaining hands-on experience in diagnosing and treating pediatric conditions. In 2019, she joined the Department of Medical Genetics at the Medical University of Plovdiv as an Assistant Professor, where she has been actively involved in teaching, research, and clinical duties. Her role at the university involves integrating her advanced knowledge of genetics into both academic instruction and patient care. Dr. Miteva-Marcheva has contributed to several strategic research projects, including the SRIPD-MUP, and has published multiple articles in high-impact journals. Her experience extends to mentoring students and collaborating with industry professionals, making her a well-rounded expert in Medical Genetics.

Research Focus 

Dr. Nelly Miteva-Marcheva’s research is at the forefront of Medical Genetics, with a particular emphasis on personalized medicine. Her work explores the genetic factors influencing patient responses to treatment, aiming to tailor therapies to individual genetic profiles. One of her notable research areas is the implementation of DPYD testing in cancer patients, which helps to predict and prevent severe toxic reactions to chemotherapy. Additionally, Dr. Miteva-Marcheva’s research in pharmacogenetics focuses on understanding how genetic variations affect drug efficacy and safety, particularly in oncology. Her contributions to these fields not only enhance patient care but also pave the way for more personalized and effective treatment strategies. Dr. Miteva-Marcheva’s ongoing research endeavors continue to push the boundaries of medical science, with the goal of integrating advanced genetic testing into routine clinical practice.

Publication Top Notes

Conclusion

Dr. Nelly Miteva-Marcheva is a highly qualified candidate for the Best Researcher Award. Her expertise in Medical Genetics, strong academic background, and impactful research contributions, particularly in pharmacogenetics and oncology, make her a strong contender for this recognition. While there are opportunities for growth in expanding her research influence and taking on more leadership roles, her current achievements position her well for this award.